betulinic acid has been researched along with Cancer of Ovary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, RK; Kingston, DG; Prakash Chaturvedula, VS; Schilling, JK | 1 |
| Al-Harrasi, A; Csuk, R; Serbian, I; Siewert, B | 1 |
| Jin, X; Lv, H; Zhang, Z; Zhou, J | 1 |
| Liao, L; Liu, C; Xie, X; Zhou, J | 1 |
| Dou, YC; Liu, JB; Wang, YJ | 1 |
| El-Deiry, WS; Meng, RD | 1 |
6 other study(ies) available for betulinic acid and Cancer of Ovary
| Article | Year |
|---|---|
New cytotoxic lupane triterpenoids from the twigs of Coussarea paniculata.
Topics: Antineoplastic Agents, Phytogenic; Drug Screening Assays, Antitumor; Female; Guyana; Humans; Inhibitory Concentration 50; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Ovarian Neoplasms; Plant Stems; Plants, Medicinal; Rubiaceae; Stereoisomerism; Triterpenes; Tumor Cells, Cultured | 2003 |
2-O-(2-chlorobenzoyl) maslinic acid triggers apoptosis in A2780 human ovarian carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Molecular Conformation; NIH 3T3 Cells; Ovarian Neoplasms; Structure-Activity Relationship; Triterpenes | 2019 |
Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arginine; Aspartic Acid; Betulinic Acid; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Compounding; Drug Liberation; Female; Glycine; Humans; Hydrogen-Ion Concentration; Indazoles; Leukocyte Count; Ligands; Mice; Micelles; Oligopeptides; Ovarian Neoplasms; Pentacyclic Triterpenes; Tissue Distribution; Triterpenes; Xenograft Model Antitumor Assays | 2019 |
Betulinic acid induces apoptosis and impairs migration and invasion in a mouse model of ovarian cancer.
Topics: Animals; Apoptosis; Betulinic Acid; Cell Line, Tumor; Cell Movement; Female; Humans; Mice; Ovarian Neoplasms; Pentacyclic Triterpenes | 2020 |
Sequential treatment with betulinic acid followed by 5-fluorouracil shows synergistic cytotoxic activity in ovarian cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Blotting, Western; Carcinoma; Cell Line, Tumor; Drug Synergism; Female; Flow Cytometry; Fluorouracil; Hedgehog Proteins; Humans; Ovarian Neoplasms; Pentacyclic Triterpenes; Triterpenes | 2015 |
p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma.
Topics: Antibiotics, Antineoplastic; Apoptosis; Betulinic Acid; Colonic Neoplasms; Dactinomycin; Dexamethasone; DNA-Binding Proteins; Female; Glioblastoma; Glucocorticoids; Humans; Interferon-gamma; Melanoma; Mutation; Naphthoquinones; Ovarian Neoplasms; Pentacyclic Triterpenes; Prednisolone; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; RNA, Messenger; STAT1 Transcription Factor; Trans-Activators; Triterpenes; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 2001 |